Terms: = Leukemia AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Staging
3 results:
1. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.
Kemps PG; Hebeda KM; Pals ST; Verdijk RM; Lam KH; Bruggink AH; de Lil HS; Ruiterkamp B; de Heer K; van Laar JA; Valk PJ; Mutsaers P; Levin MD; Hogendoorn PC; van Halteren AG
J Pathol Clin Res; 2021 Jan; 7(1):10-26. PubMed ID: 32852896
[TBL] [Abstract] [Full Text] [Related]
2. A pooled exploratory analysis of the effect of tumor size and kras mutations on survival benefit from adjuvant platinum-based chemotherapy in node-negative non-small cell lung cancer.
Cuffe S; Bourredjem A; Graziano S; Pignon JP; Domerg C; Ezzalfani M; Seymour L; Strevel E; Burkes R; Capelletti M; Jänne PA; Tsao MS; Shepherd FA
J Thorac Oncol; 2012 Jun; 7(6):963-72. PubMed ID: 22588152
[TBL] [Abstract] [Full Text] [Related]
3. [Current options and principles of pathomorphology-based tumour diagnostics].
Povýsil C
Vnitr Lek; 2010 Jul; 56(7):709-14. PubMed ID: 20842917
[TBL] [Abstract] [Full Text] [Related]
